Varex Imaging [VREX] vs Enovis [ENOV] Detailed Stock Comparison
Varex Imaging
NASDAQ
Loading...
Enovis
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Varex Imaging wins in 9 metrics, Enovis wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Varex Imaging | Enovis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 19.08 | -2.07 | Enovis |
| Price-to-Book Ratio | 1.05 | 0.68 | Enovis |
| Debt-to-Equity Ratio | 84.54 | 56.75 | Enovis |
| PEG Ratio | 0.00 | -0.02 | Enovis |
| EV/EBITDA | -78.49 | 8.79 | Varex Imaging |
| Profit Margin (TTM) | -16.13% | -37.80% | Varex Imaging |
| Operating Margin (TTM) | -39.75% | 2.41% | Enovis |
| EBITDA Margin (TTM) | N/A | 2.41% | N/A |
| Return on Equity | -24.79% | -28.25% | Varex Imaging |
| Return on Assets (TTM) | -1.96% | 0.89% | Enovis |
| Free Cash Flow (TTM) | $20.40M | $-67.21M | Varex Imaging |
| 1-Year Return | -7.45% | -33.69% | Varex Imaging |
| Price-to-Sales Ratio (TTM) | 0.58 | 0.81 | Varex Imaging |
| Enterprise Value | $737.83M | $3.19B | Enovis |
| EV/Revenue Ratio | 0.90 | 1.46 | Varex Imaging |
| Gross Profit Margin (TTM) | 33.25% | 59.29% | Enovis |
| Revenue per Share (TTM) | $20 | $39 | Enovis |
| Earnings per Share (Diluted) | $-3.23 | $-14.95 | Varex Imaging |
| Beta (Stock Volatility) | 0.68 | 1.81 | Varex Imaging |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Varex Imaging vs Enovis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Varex Imaging | 0.70% | -0.60% | 47.89% | 46.57% | -10.19% | -19.85% |
| Enovis | 1.01% | -1.72% | 13.10% | -3.59% | -20.05% | -30.25% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Varex Imaging | -7.45% | -46.23% | 6.55% | -54.55% | -54.55% | -54.55% |
| Enovis | -33.69% | -36.93% | -46.76% | -50.61% | 30.77% | -12.41% |
Performance & Financial Health Analysis: Varex Imaging vs Enovis
| Metric | VREX | ENOV |
|---|---|---|
| Market Information | ||
| Market Cap | $529.41M | $2.16B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 367,070 | 878,688 |
| 90 Day Avg. Volume | 477,890 | 1,164,626 |
| Last Close | $11.55 | $30.90 |
| 52 Week Range | $6.76 - $16.93 | $25.47 - $49.83 |
| % from 52W High | -31.78% | -37.99% |
| All-Time High | $43.76 (Jan 29, 2018) | $129.72 (Jun 09, 2014) |
| % from All-Time High | -73.61% | -76.18% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.03% | 0.08% |
| Quarterly Earnings Growth | N/A | 0.08% |
| Financial Health | ||
| Profit Margin (TTM) | -0.16% | -0.38% |
| Operating Margin (TTM) | -0.40% | 0.02% |
| Return on Equity (TTM) | -0.25% | -0.28% |
| Debt to Equity (MRQ) | 84.54 | 56.75 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $10.97 | $45.11 |
| Cash per Share (MRQ) | $3.68 | $0.77 |
| Operating Cash Flow (TTM) | $59.70M | $188.06M |
| Levered Free Cash Flow (TTM) | $-4,112,500 | $65.68M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Varex Imaging vs Enovis
| Metric | VREX | ENOV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 19.08 | -2.07 |
| Forward P/E | 17.24 | 9.78 |
| PEG Ratio | 0.00 | -0.02 |
| Price to Sales (TTM) | 0.58 | 0.81 |
| Price to Book (MRQ) | 1.05 | 0.68 |
| Market Capitalization | ||
| Market Capitalization | $529.41M | $2.16B |
| Enterprise Value | $737.83M | $3.19B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.90 | 1.46 |
| Enterprise to EBITDA | -78.49 | 8.79 |
| Risk & Other Metrics | ||
| Beta | 0.68 | 1.81 |
| Book Value per Share (MRQ) | $10.97 | $45.11 |
Financial Statements Comparison: Varex Imaging vs Enovis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VREX | ENOV |
|---|---|---|
| Revenue/Sales | $212.90M | $558.83M |
| Cost of Goods Sold | $136.20M | $226.61M |
| Gross Profit | $76.70M | $332.23M |
| Research & Development | $22.00M | $28.53M |
| Operating Income (EBIT) | $22.10M | $-42.91M |
| EBITDA | $26.80M | $27.14M |
| Pre-Tax Income | $10.80M | $-57.35M |
| Income Tax | $3.70M | $-1.77M |
| Net Income (Profit) | $7.10M | $-55.71M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VREX | ENOV |
|---|---|---|
| Cash & Equivalents | $205.10M | $38.46M |
| Total Current Assets | $683.80M | $1.22B |
| Total Current Liabilities | $168.80M | $477.42M |
| Long-Term Debt | $585.40M | $1.42B |
| Total Shareholders Equity | $563.90M | $2.62B |
| Retained Earnings | $77.00M | $-338.99M |
| Property, Plant & Equipment | $177.60M | $492.24M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VREX | ENOV |
|---|---|---|
| Operating Cash Flow | $11.60M | $-1.07M |
| Capital Expenditures | $-6.80M | $-43.26M |
| Free Cash Flow | $9.80M | $-44.86M |
| Debt Repayment | $-400,000 | $-15.44M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VREX | ENOV |
|---|---|---|
| Shares Short | 1.22M | 6.64M |
| Short Ratio | 2.44 | 4.25 |
| Short % of Float | 0.03% | 0.17% |
| Average Daily Volume (10 Day) | 367,070 | 878,688 |
| Average Daily Volume (90 Day) | 477,890 | 1,164,626 |
| Shares Outstanding | 41.09M | 55.88M |
| Float Shares | 40.96M | 56.43M |
| % Held by Insiders | 0.02% | 0.02% |
| % Held by Institutions | 0.96% | 1.21% |
Dividend Analysis & Yield Comparison: Varex Imaging vs Enovis
| Metric | VREX | ENOV |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |